Ampio Pharmaceuticals, Inc. (Ampio) is a development-stage biopharmaceutical company focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company is primarily focused on providing medicines to improve the health and quality of life of patients with minimal side effects. Ampio is engaged in developing pharmaceutical drugs and diagnostic products to identify, treat and prevent a range of human diseases, including metabolic disorders, eye disease, kidney disease, acute and chronic inflammation diseases and male sexual dysfunction. The Company is also focused on monetizing its sexual dysfunction portfolio and a diagnostic device. In February 2013, it announced the incorporation and initiation of operations of Luoxis Diagnostics.